Immune checkpoint inhibitor therapy for hepatocellular carcinoma
Daryl Ramai, Alexandra Shapiro, Antonio Facciorusso, Claudia Bareggi, Donatella Gambini, Erika Rijavec, Gianluca Tomasello, Barbara Galassi, Michele Ghidini
Baseline serum Mac-2 binding protein glycosylation isomer as a predictor of hepatocellular carcinoma in chronic hepatitis B patients: a systematic review and meta-analysis
Andro Pramana Witarto, Bendix Samarta Witarto, Shidi Laras Pramudito, Achmad Januar Er Putra, Grace Manuela Nurhadi, Ummi Maimunah
Efficacy and safety of endoscopic drainage of peripancreatic fluid collections: a retrospective multicenter European study
Paraskevas Gkolfakis, Maria Chiara Petrone, Mario Tadic, Georgios Tziatzios, Ioannis Karoumpalis, Stefano Francesco Crinò, Antonio Facciorusso, Istvan Hritz, Dimitrios Kypraios, Athanasios D. Sioulas, Ilias Scotiniotis, Antonios Vezakis, Bank Keczer, Eleni Koukoulioti, Nicola Muscatiello, Konstantinos Triantafyllou, Andreas Polydorou, Ivica Grgurevic, Paolo Giorgio Arcidiacono, Ioannis S. Papanikolaou
Endoscopic ultrasonography-guided biliary drainage for malignant jaundice by using electrocautery-enhanced lumen-apposing metal stents (Hot-SPAXUS stent)
Raffaele Manta, Sabrina Torrisi, Danilo Castellani, Ugo Germani, Francesco P. Zito, Olivia Morelli, Paolo M. Brunori, Angelo Zullo, Vincenzo De Francesco
First Impact Factor coming in 2023
We are delighted to announce that Annals of Gastroenterology will receive its first Impact Factor in 2023. According to Clarivate’s announcement on 26th July 2022, all journals currently in their ESCI collection, where Annals of Gastroenterology is presently indexed, will be awarded with an IF in June 2023.
